1 min read
Press Releases
2 min read
AGC Biologics and Horizon Therapeutics plc Expand Partnership
1 min read
MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition
2 min read
AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions
2 min read
AGC Biologics Appoints Luca Alberici as the New General Manager/Site Head of the Milan, Italy Site
2 min read
AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab
1 min read
AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage
2 min read